Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Dermatology

  Free Subscription


13.07.2026

1 Am J Dermatopathol
2 Am J Ophthalmol
3 BMC Cancer
2 Br J Dermatol
4 Cancer
3 Cancer Lett
9 Clin Dermatol
4 Clin Exp Dermatol
7 Cutis
5 Int J Cancer
9 Int J Dermatol
4 J Cutan Pathol
15 J Dermatol
6 J Invest Dermatol
1 N Engl J Med
1 PLoS Med
9 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. HAIDUK II, Podyacheva OA, Vladimirkina MS, Davydova DA, et al
    Myxoid Variant of Primary Cutaneous Anaplastic Large Cell Lymphoma Mimicking Soft Tissue Sarcoma: Diagnostic Pitfalls and Literature Review.
    Am J Dermatopathol. 2026 Jul 6. doi: 10.1097/DAD.0000000000003380.
    PubMed         Abstract available


    Am J Ophthalmol

  2. PLACIDE J, Phan M, Tedla S, Kay PS, et al
    Ocular Symptoms Lead to Shortest Diagnostic Delay in Biopsy-Proven Giant Cell Arteritis: A Nationwide Veterans Health Study.
    Am J Ophthalmol. 2026 Apr 20:S0002-9394(26)00210.
    PubMed         Abstract available

  3. SHRINKHAL, Shukla A, Prasad N
    Medial Canthal Eyelid Acrochordon Presenting as a Cutaneous Horn in Young Girl.
    Am J Ophthalmol. 2026 Jul 9:S0002-9394(26)00373.
    PubMed        


    BMC Cancer

  4. KANO M, Furusawa A, Fukushima H, Takao S, et al
    Human epidermal growth factor receptor 3-targeted near-infrared photoimmunotherapy in a xenograft mouse model of breast cancer.
    BMC Cancer. 2026 May 18. doi: 10.1186/s12885-026-16170.
    PubMed         Abstract available

  5. XIAO WT, He JY, Yang D, Xun Y, et al
    Construction of a novel signature based on CRISPR-Cas9 screening for prognostic prediction in breast cancer.
    BMC Cancer. 2026 May 14. doi: 10.1186/s12885-026-16167.
    PubMed         Abstract available

  6. SETIAWAN G, Azhar Y, Abdurahman M, Soemitro MP, et al
    De-escalation of chemotherapy in HER2-positive breast cancer management: a systematic review and meta-analysis.
    BMC Cancer. 2026 May 14. doi: 10.1186/s12885-026-16149.
    PubMed         Abstract available


    Br J Dermatol

  7. MISKY AT, Paiva M, Woltynski C, Bagirathan S, et al
    Shallow Cuts, Deeper Issues: The Primacy of Deep Margins in Cutaneous Squamous Cell Carcinoma.
    Br J Dermatol. 2026 Jul 6:ljag269. doi: 10.1093.
    PubMed        

  8. ELYAS A, Mohareb AM, Rossoni I, Shahla WA, et al
    Quality-of-Life Measurement in Migrants and Other Vulnerable Groups: Experience with Skindex-16 in Malta and Lebanon.
    Br J Dermatol. 2026 Jul 6:ljag267. doi: 10.1093.
    PubMed        


    Cancer

  9. ARENA L, Alizai Q, Elemosho A, Chatzipanagiotou OP, et al
    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.
    Cancer. 2026;132:e70462.
    PubMed         Abstract available

  10. BERCIANO-GUERRERO MA, Perez-Ruiz E, Soria A, Medina Martinez J, et al
    Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.
    Cancer. 2026;132:e70497.
    PubMed         Abstract available

  11. DI COSIMO S, Appierto V, Reduzzi C, De Cecco L, et al
    Circulating tumor DNA in early breast cancer: Evidence, challenges, next steps.
    Cancer. 2026;132:e70521.
    PubMed         Abstract available

  12. GENTRY AL, Sereika SM, Erickson KI, McCall MK, et al
    The relationship of neighborhood socioeconomic disadvantage and pretreatment cancer-related cognitive impairment in women with breast cancer: A post hoc analysis of a randomized controlled trial.
    Cancer. 2026;132:e70506.
    PubMed         Abstract available


    Cancer Lett

  13. LIN LL, Bai JW, Song L, Lou KL, et al
    GSH-Activatable Rare-Earth Nanoprobe for NIR-II Fluorescence Imaging-Guided Surgery and Enhanced Chemotherapy/Chemodynamic Therapy of Breast Cancer.
    Cancer Lett. 2026 Jun 11:218677. doi: 10.1016/j.canlet.2026.218677.
    PubMed         Abstract available

  14. TAN C, Lyu H, Ruan S, Wu Y, et al
    Subtype-specific HER3 enrichment in basal-like breast cancer is regulated via the GATA2/GATA3-FOXA1 axis.
    Cancer Lett. 2025 Sep 2:218001. doi: 10.1016/j.canlet.2025.218001.
    PubMed         Abstract available

  15. LI C, Gao T, Zhao Q, Li Z, et al
    Inhibition of CPT1A activates the cGAS/STING pathway to enhance neutrophil-mediated tumor abrogation in triple-negative breast cancer.
    Cancer Lett. 2025;633:217991.
    PubMed         Abstract available


    Clin Dermatol

  16. ZIENELDIEN T, Ma S, Kim J, Tan I, et al
    Faith and fasting in dermatology: Ethical dilemmas in pharmacologic treatment.
    Clin Dermatol. 2026;44:600-603.
    PubMed         Abstract available

  17. HOENIG LJ, Wollina U, Levell NJ, Parish LC, et al
    The Declaration of Independence from a dermatology perspective.
    Clin Dermatol. 2026;44:641-649.
    PubMed         Abstract available

  18. COHEN PR, Weinberg JM, Hoenig LJ, Parish LC, et al
    Forensic dermatology and the crime scene investigation (CSI) effect: Are jurors influenced by forensic dermatologic investigations that they view on television, printed media, and the internet?
    Clin Dermatol. 2026;44:650-668.
    PubMed         Abstract available

  19. GEZMEN S, Turkili S, Kroumpouzos G, Tursen U, et al
    Sleep quality in patients with mycosis fungoides and its relationship with dermatology-specific quality of life.
    Clin Dermatol. 2026;44:592-597.
    PubMed         Abstract available

  20. ALTAN FERHATOGLU Z, Ozkoca D, Tuzun Y
    Chronic ear pruritus.
    Clin Dermatol. 2026;44:521-527.
    PubMed         Abstract available

  21. WOLLINA U, Chiriac A
    Benign tumors of the auricle and the external auditory canal.
    Clin Dermatol. 2026;44:534-550.
    PubMed         Abstract available

  22. BAYKAL C, Atci T
    Epithelial and nonepithelial tumors of the external ear.
    Clin Dermatol. 2026;44:551-564.
    PubMed         Abstract available

  23. BILGEN AS, Karadag AS, Colcinar A, Karakol P, et al
    Dermatosurgical approach to the ear.
    Clin Dermatol. 2026;44:565-578.
    PubMed         Abstract available

  24. GUIDA S, De Rosa C, Bottino V, Rongioletti F, et al
    Ear manifestations of connective tissue diseases: A dermatologic, histopathologic, and clinicopathologic review.
    Clin Dermatol. 2026;44:528-533.
    PubMed         Abstract available


    Clin Exp Dermatol

  25. NAPOLITANO M, Lauletta G, Cimmino M, Girolomoni G, et al
    Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study.
    Clin Exp Dermatol. 2026 Jul 9:llag285. doi: 10.1093.
    PubMed         Abstract available

  26. HANG X, Ling N
    Familial Pigmented Fungiform Papillae of the Tongue Across Three Generations with Concurrent Cutaneous Hyperpigmentation.
    Clin Exp Dermatol. 2026 Jul 9:llag287. doi: 10.1093.
    PubMed        

  27. WIENHOLTZ NKF, Egeberg A, Kezic S, Ungar B, et al
    Cutaneous inflammatory biomarkers in rosacea and their association with disease severity.
    Clin Exp Dermatol. 2026 Jul 8:llag281. doi: 10.1093.
    PubMed         Abstract available

  28. CONLON O, Herlihy M, Safta Y, Goh Y, et al
    Guselkumab for checkpoint inhibitor-exacerbated psoriasis in a patient with metastatic melanoma.
    Clin Exp Dermatol. 2026 Jul 6:llag280. doi: 10.1093.
    PubMed        


    Cutis

  29. CHEN XR, Zhu JW, Wang YJ
    Multiple Papules and Pustules on the Face and Neck.
    Cutis. 2026;117:E7-E9.
    PubMed        

  30. TEJAWINATA FI, Rohr BR
    Solitary Papule on the Upper Back.
    Cutis. 2026;117:114-128.
    PubMed        

  31. FENSTERMACHER S, Araoye E, Ho J, English JC 3rd, et al
    Xylazine-Induced Skin Necrosis.
    Cutis. 2026;117:E10-E11.
    PubMed        

  32. KASSIRA NR, Carley SK
    The Effect of GLP-1 Receptor Agonists on Hidradenitis Suppurativa: A Comprehensive Systematic Review.
    Cutis. 2026;117:E19-E22.
    PubMed         Abstract available

  33. QUILLIN K, Kuceki G, Seline P
    Cutaneous Manifestations of Neglected Infectious Diseases in US Military Personnel.
    Cutis. 2026;117:118-121.
    PubMed         Abstract available

  34. ALLADEEN A, Cho SK, Micheletti RG
    Hospital Dermatology: Review of Research in 2024-2025.
    Cutis. 2026;117:109-113.
    PubMed         Abstract available

  35. GAMES MP, Schwartz L, Lipoff JB
    Microcystic Adnexal Carcinoma-like Neoplasm in a Patient With POT1 Mutation.
    Cutis. 2026;117:E23-E27.
    PubMed         Abstract available


    Int J Cancer

  36. MAES-CARBALLO M, de-la-Puente-Mota N, Sampol-Ramirez L, Martinez-Martinez C, et al
    Integrating Shared Decision-Making Into Breast Cancer Postmastectomy Reconstruction: A Systematic Review of Evidence, Barriers, and Real-World Implementation.
    Int J Cancer. 2026 May 7. doi: 10.1002/ijc.70493.
    PubMed         Abstract available

  37. BAR M, Widlak W, Vydra N
    Targeting ERalpha Coregulator Networks to Overcome Endocrine Resistance in ER+ Breast Cancer.
    Int J Cancer. 2026 May 4. doi: 10.1002/ijc.70522.
    PubMed         Abstract available

  38. PANTELAIOU-PROKAKI G, Bamahmoud H, Georges NS, Jansari S, et al
    MUC1 as a Survival Effector of Radiotherapy-Induced Epithelial Hybrid States in Basal-Like Breast Cancer.
    Int J Cancer. 2026 Apr 18. doi: 10.1002/ijc.70487.
    PubMed         Abstract available

  39. MALCOMSON L, Brentnall A, Renehan AG, Pegington M, et al
    Age at First Pregnancy, Adult Weight Gain and Postmenopausal Breast Cancer Risk: The PROCAS Study (United Kingdom).
    Int J Cancer. 2026 Apr 12. doi: 10.1002/ijc.70489.
    PubMed         Abstract available

  40. JAVAID A, Peres T, Schmitt AM, Larkin J, et al
    10-Years of First-Line Ipilimumab and Nivolumab in Advanced Melanoma: A Single Centre Experience.
    Int J Cancer. 2026 Jul 9. doi: 10.1002/ijc.70653.
    PubMed         Abstract available


    Int J Dermatol

  41. MANRIQUE-SILVA E, Aguerralde-Martin M, Garcia-Casado Z, Millan-Esteban D, et al
    Association Between pTERT Promoter Mutation Subtypes and Survival Outcomes in BRAF-Mutant Metastatic Melanoma Treated With BRAF/MEK Inhibitors: An Exploratory Study.
    Int J Dermatol. 2026 Jul 7. doi: 10.1111/ijd.70553.
    PubMed         Abstract available

  42. PODOLSKY AS, Lipner SR
    Immune Checkpoint Inhibitors are Associated With Increased Risk of Lichen Planus in a TriNetX Analysis.
    Int J Dermatol. 2026 Jul 7. doi: 10.1111/ijd.70576.
    PubMed        

  43. LONDONO-GARCIA AM, Castro-Ayarza JR, Franco Franco MD, Cardenas Rojas PJ, et al
    Treat-To-Target Goals for Atopic Dermatitis in Colombia: A Modified Delphi Consensus From the Colombian Group of Psoriasis and Immunodermatology (COLPSOR).
    Int J Dermatol. 2026 Jul 10. doi: 10.1111/ijd.70569.
    PubMed         Abstract available

  44. AKDOGAN N, Kaymak MK, Bosnak C, Sonmezer MC, et al
    Clinical Characteristics, Genomic Sequencing, and Treatment Response of 13 Cases Infected With the Emerging Pathogen, Trichopyhton indotineae, From Turkiye.
    Int J Dermatol. 2026;65:1668-1675.
    PubMed         Abstract available

  45. TRAINI DO, Palmisano G, Ciobotariu I, Casciola M, et al
    Line Field Confocal Optical Coherence Tomography (LC-OCT) Features of Primary Cicatricial Alopecias.
    Int J Dermatol. 2026;65:1641-1646.
    PubMed         Abstract available

  46. MICHELINI S, Scribani Rossi P, Gemma G, Persechino F, et al
    Assessing the Dermal Epidermal Junction of Hyperkeratotic Actinic Keratoses via Line-Field Confocal Optical Coherence Tomography.
    Int J Dermatol. 2026;65:1676-1680.
    PubMed         Abstract available

  47. AKAMINE AA, Macagnan MC, Zenedin Marchioro H
    Infiltrated Facial Plaques With 40-Year Evolution.
    Int J Dermatol. 2026;65:1587-1589.
    PubMed         Abstract available

  48. SECHI A, Starace M, Valtellini L, Pampaloni F, et al
    Beyond the Plate: Nail Bed Dermoscopy for Differentiation of Psoriatic, Fungal, and Traumatic Fingernail Onycholysis.
    Int J Dermatol. 2026;65:1633-1640.
    PubMed         Abstract available

  49. KEMENY L
    Editor's Highlights-August 2026.
    Int J Dermatol. 2026;65:1579-1580.
    PubMed         Abstract available


    J Cutan Pathol

  50. HANLY A, Panse G, Myung P, Ko CJ, et al
    The Histopathological Features of Secondary Syphilis: A Case Series.
    J Cutan Pathol. 2026;53:724-730.
    PubMed         Abstract available

  51. JIANG J, Say B, Brown R, Rieger K, et al
    Superficial CIC::DUX4 Sarcoma With Focal WT1 Expression: Histomorphologic Clues and Immunohistochemical Pitfalls.
    J Cutan Pathol. 2026;53:687-691.
    PubMed         Abstract available

  52. TUCCI C, Weston GK, Sloan B, Criscito MC, et al
    Novel Histopathologic Features of Median Canaliform Dystrophy.
    J Cutan Pathol. 2026;53:678-681.
    PubMed         Abstract available

  53. TAN XL, Patel P, Cernova J, Hogan S, et al
    Squamoid Eccrine Ductal Carcinoma: Case Series of a Rare, Potentially Aggressive Skin Cancer Associated With Immunosuppression.
    J Cutan Pathol. 2026 Jul 8. doi: 10.1111/cup.70127.
    PubMed         Abstract available


    J Dermatol

  54. ASADA S, Hoshina D
    Pembrolizumab-Associated Lichen Striatus in an Adult.
    J Dermatol. 2026 Jul 6. doi: 10.1111/1346-8138.70381.
    PubMed        

  55. TANAKA Y, Aoki N, Yamamoto M, Nakai K, et al
    Exacerbation of Psoriasis Following Recurrence of Lymphangioma: A Case Report.
    J Dermatol. 2026 Jul 6. doi: 10.1111/1346-8138.70384.
    PubMed        

  56. KOMORI T, Nakano E, Kiniwa Y, Mori S, et al
    Efficacy of Adjuvant Interferon-beta Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.
    J Dermatol. 2026 Jul 6. doi: 10.1111/1346-8138.70375.
    PubMed         Abstract available

  57. KAGOYAMA K, Makino T, Tsuritani M, Furukawa F, et al
    Fractional CO(2) Laser in Lichen Amyloidosis With Rapid Pruritus Resolution and Long-Term Remission: Serial PGP9.5 and Dylon Observations With Touch Sensitivity Assessment.
    J Dermatol. 2026 Jul 8. doi: 10.1111/1346-8138.70385.
    PubMed         Abstract available

  58. ZHANG S, Pang Z, Liu J
    Mycosis Fungoides Following IL-17 Inhibitor Treatment: A Case Series of Five Patients.
    J Dermatol. 2026;53:1036-1042.
    PubMed         Abstract available

  59. NISHIDA M, Shimauchi T, Ishikawa Y, Ogura Y, et al
    Pustular Mycosis Fungoides Triggered by Systemic Interferon-gamma.
    J Dermatol. 2026;53:1032-1035.
    PubMed         Abstract available

  60. SUZAKI Y, Aoyama Y
    Drug-Induced Blaschkitis Associated With Dipeptidyl Peptidase-4 Inhibitor: A Case Report and Review of the Literature.
    J Dermatol. 2026;53:1048-1052.
    PubMed         Abstract available

  61. ASHIDA M, Nakahara T, Murota H
    Persistent Blood Dioxins and Sensory Impairment Assessed by Quantitative Sensory Testing in 115 Yusho Patients 57 Years After Exposure.
    J Dermatol. 2026;53:1053-1056.
    PubMed         Abstract available

  62. MARUYAMA A, Sotozono A, Fukumoto T
    Acquired Idiopathic Generalized Anhidrosis as a Late-Onset Immune-Related Adverse Event of Pembrolizumab in a Patient With Lung Adenocarcinoma: A Case Report and Review of the Literature.
    J Dermatol. 2026;53:1072-1076.
    PubMed         Abstract available

  63. OTSUKA A, Tsunemi Y, Nonaka Y
    Patient Characteristics Associated With Sensitivity to Message Framing: A Within-Subject Comparison Study Using Data From the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) Survey.
    J Dermatol. 2026;53:1067-1071.
    PubMed         Abstract available

  64. INOUE T, Watabe D, Sato T, Yasuhira S, et al
    Baseline Nail Thickness and Great Toenail Involvement Are Associated With Poor Response to Topical Antifungal Therapy for Onychomycosis: A Lesion-Level Generalized Estimating Equations Analysis.
    J Dermatol. 2026;53:1013-1019.
    PubMed         Abstract available

  65. JENG YC, Liu WT, Hsu CK, Yang CC, et al
    Real-World Experience With Single Ultra-Low Dose Rituximab for Remission Induction in Pemphigus.
    J Dermatol. 2026;53:1057-1061.
    PubMed         Abstract available

  66. PUIG L, Tsai TF, Soriano ER, Bhutani T, et al
    Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.
    J Dermatol. 2026;53:1026-1031.
    PubMed         Abstract available

  67. WALTER T, Burckhardt BB
    Broadening the View: Substance P and Its Metabolism in Pruritus-Related Diseases.
    J Dermatol. 2026;53:967-979.
    PubMed         Abstract available

  68. TERUI T, Kobayashi S, Yamamoto T, Okubo Y, et al
    Treatment Guidance for Palmoplantar Pustulosis 2022.
    J Dermatol. 2026;53:e510-e566.
    PubMed         Abstract available


    J Invest Dermatol

  69. ILIC D, Dubrac S, Tanaka RJ, Gulseren G, et al
    Reducing plastic waste in skin-model research: Sustainable packaging as a practical first step.
    J Invest Dermatol. 2026 Jul 4:S0022-202X(26)01273.
    PubMed        

  70. CHOUSAKOS E, Stratigos A
    Introducing lesion-level metrics for melanocytic neoplasm clustering: Practical tools with potential applications in clinical practice.
    J Invest Dermatol. 2026 Jul 7:S0022-202X(26)01269.
    PubMed        

  71. FONFARA M, Stolzl D, Hartmann J, Harder I, et al
    Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: an analysis from the TREATKids registry.
    J Invest Dermatol. 2026 Jul 7:S0022-202X(26)02663.
    PubMed         Abstract available

  72. EYLENBOSCH A, Soenen R, van Riel CAM, van den Reek JM, et al
    Population Pharmacokinetic-Pharmacodynamic Model for Secukinumab in Psoriasis Patients.
    J Invest Dermatol. 2026 Jul 8:S0022-202X(26)02665.
    PubMed         Abstract available

  73. SUGIMOTO E, Mima Y, Yamamoto T, Koyama A, et al
    Polycomb protein EED supports ultraviolet-induced effector regulatory T cell responses in cutaneous inflammation.
    J Invest Dermatol. 2026 Jul 9:S0022-202X(26)02664.
    PubMed        

  74. ZHEVLAKOVA I, Molokotina I, Burrows AC, Horak AJ 3rd, et al
    Gut Microbiota Shapes the Effects of Saturated and Polyunsaturated Fatty Acids on Skin and Hair Follicle Homeostasis.
    J Invest Dermatol. 2026 Jul 9:S0022-202X(26)02668.
    PubMed         Abstract available


    N Engl J Med

  75. MILLER JL, van Santen HM, Phillips SA, Hamilton J, et al
    Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.
    N Engl J Med. 2026;395:138-150.
    PubMed         Abstract available


    PLoS Med

  76. ARUNDEL C, Welch C, Strachan L, Peck C, et al
    Compression therapies for venous leg ulcers: The VENous Ulcer Study 6 (VenUS 6), an open, multicentre, randomised clinical trial.
    PLoS Med. 2026;23:e1005154.
    PubMed         Abstract available


    PLoS One

  77. ALSUNBUL M, Zaki RM, Alnuwaybit GN, Aljunayh FA, et al
    Topical sterosomes-based nanocarrier of miconazole for the management of cutaneous candidiasis.
    PLoS One. 2026;21:e0353060.
    PubMed         Abstract available

  78. GRUNFELD AM, Bokros M, Paz K, Bilbao D, et al
    Amyloid-bodies in the evolution of malignancies.
    PLoS One. 2026;21:e0353464.
    PubMed         Abstract available

  79. CORTES JA, Aflatooni S, Ure A, Palma G, et al
    A practical inflammatory blood-cell marker for cardiovascular risk stratification in psoriasis: Development of the Platelet-Leukocyte Adjusted Cardiovascular (PLAC) score.
    PLoS One. 2026;21:e0353475.
    PubMed         Abstract available

  80. HOVDA T, Sober S, Padrik P, Kruuv-Kao K, et al
    A clinical pilot study for personalized risk-based breast cancer screening utilizing a polygenic risk score.
    PLoS One. 2026;21:e0345431.
    PubMed         Abstract available

  81. XIANG Y, Deng H, Wang Y, Yan N, et al
    Bioinformatics analysis reveals the characteristics of immune microenvironment in major depressive disorder and vitiligo.
    PLoS One. 2026;21:e0352672.
    PubMed         Abstract available

  82. LEE JS, Ahn HK, Cho SI, Mun JH, et al
    Machine learning reveals distinct temperature thresholds and environmental modulators for atopic dermatitis and allergic contact dermatitis prevalence in South Korea.
    PLoS One. 2026;21:e0352199.
    PubMed         Abstract available

  83. ATTAR RZ, Movahedi M, Cesta A, Li X, et al
    Improving outcomes of patients living with psoriatic arthritis: The Observational Best Practices Research Initiative (OBRI-PsA) registry: Rationale, Methodology and Preliminary Data of 18 Months Follow-up.
    PLoS One. 2026;21:e0352264.
    PubMed         Abstract available

  84. SONG SG, Cho SI, Sim T, Shin S, et al
    Artificial intelligence-detected HER2 strong-positive tumor proportion predicts FISH positivity and treatment response in breast cancer.
    PLoS One. 2026;21:e0352979.
    PubMed         Abstract available

  85. NGUYEN V, Pham TV, Dinh TH, Tran DN, et al
    Age and tumor size as independent predictors of malignancy in BI-RADS 4 and 5 breast lesions: A cross-sectional study in Vietnam.
    PLoS One. 2026;21:e0352690.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  86. HARADA Y, Sasaki T, Obata-Ninomiya K, Matsuyama T, et al
    IL-13 signaling in cDC2 is required for systemic anaphylactic responses.
    Proc Natl Acad Sci U S A. 2026;123:e2608478123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum